Capzer PharmaceuticalsJuly 24, 2025

FDA 483 - Capzer Pharmaceuticals - July 24, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Capzer Pharmaceuticals

Record Details

Capzer Pharmaceuticals, a control laboratory in Lake Worth Beach, FL, was inspected by the FDA, revealing significant deficiencies. The inspection found that the firm's quality control unit lacked adequately written and followed procedures, and laboratory records were incomplete, specifically missing sample collection dates. These issues indicate a failure to adhere to established quality standards for pharmaceutical operations.

Company: Capzer Pharmaceuticals
Inspection Date: July 24, 2025
Product Type: Drugs
Office: Florida District Office
Person: Frederick Razzaghi (Advisor)

Open in Dashboard

ID · edf9ece7-4632-42a0-b58d-cf359e1f588e